A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Atorvastatin; GSK 649868; Simvastatin
- Indications Cardiovascular disorders; Hypercholesterolaemia; Sleep disorders
- Focus Adverse reactions; Pharmacokinetics
- 26 Jul 2017 Last checked against ClinicalTrials.gov record.
- 25 Feb 2011 New trial record